A new cancer drug candidate developed byLawrence Livermore National Lab,BridgeBio Oncology Therapeutics and theFrederick National Laboratory for Cancer Research shows the ability to block tumor growth without a common side effect ....The post Livermore Lab: Cancer Drug Candidate Developed Using HPC and AI Blocks Tumor Growth appeared first on Inside HPC & AI News | High-Performance Computing & Artificial Intelligence.